共 50 条
Three-Year Outcomes After Sirolimus-Eluting Stent Implantation for Unprotected Left Main Coronary Artery Disease Insights From the j-Cypher Registry
被引:78
|作者:
Toyofuku, Mamoru
[4
]
Kimura, Takeshi
[1
]
Morimoto, Takeshi
[2
,3
]
Hayashi, Yasuhiko
[4
]
Ueda, Hiroaki
[4
]
Kawai, Kazuya
[8
]
Nozaki, Yoichi
[7
]
Hiramatsu, Shinichi
[6
]
Miura, Akira
[5
]
Yokoi, Yoshiaki
[13
]
Toyoshima, Shinichiro
[12
]
Nakashima, Hitoshi
[11
]
Haze, Kazuo
[10
]
Tanaka, Masaru
[9
]
Take, Shunsuke
[16
]
Saito, Shigeru
[15
]
Isshiki, Takaaki
[14
]
Mitsudo, Kazuaki
[17
]
机构:
[1] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Sakyo Ku, Kyoto 6068507, Japan
[2] Kyoto Univ, Grad Sch Med, Ctr Med Educ, Kyoto 6068507, Japan
[3] Kyoto Univ, Grad Sch Med, Clin Epidemiol Unit, Kyoto 6068507, Japan
[4] Tsuchiya Gen Hosp, Hiroshima, Japan
[5] Japanese Red Cross Soc Wakayama Med Ctr, Wakayama, Japan
[6] Ehime Prefectural Cent Hosp, Matsuyama, Ehime, Japan
[7] Hokko Mem Hosp, Sapporo, Hokkaido, Japan
[8] Chikamori Hosp, Kochi, Japan
[9] Osaka Red Cross Hosp, Osaka, Japan
[10] Osaka City Gen Hosp, Osaka, Japan
[11] Natl Hosp Org Kagoshima Med Ctr, Kagoshima, Japan
[12] Nanpuh Hosp, Kagoshima, Japan
[13] Kishiwada Tokushukai Hosp, Kishiwada, Japan
[14] Teikyo Univ Hosp, Tokyo, Japan
[15] Shonan Kamakura Gen Hosp, Kamakura, Kanagawa, Japan
[16] Saiseikai Noe Hosp, Osaka, Japan
[17] Kurashiki Cent Hosp, Kurashiki, Okayama, Japan
关键词:
stents;
revascularization;
coronary disease;
ischemia;
restenosis;
BYPASS-SURGERY;
THROMBOSIS;
STENOSIS;
SURVIVAL;
D O I:
10.1161/CIRCULATIONAHA.109.873349
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Background-Long-term outcomes after stenting of an unprotected left main coronary artery (ULMCA) with drug-eluting stents have not been addressed adequately despite the growing popularity of this procedure. Methods and Results-j-Cypher is a multicenter prospective registry of consecutive patients undergoing sirolimus-eluting stent implantation in Japan. Among 12 824 patients enrolled in the j-Cypher registry, the unadjusted mortality rate at 3 years was significantly higher in patients with ULMCA stenting (n = 582) than in patients without ULMCA stenting (n = 12 242; 14.6% versus 9.2%, respectively; P < 0.0001); however, there was no significant difference between the 2 groups in the adjusted risk of death (hazard ratio 1.23, 95% confidence interval 0.95 to 1.60, P = 0.12). Among 476 patients whose ULMCA lesions were treated exclusively with a sirolimus-eluting stent, patients with ostial/shaft lesions (n = 96) compared with those with bifurcation lesions (n = 380) had a significantly lower rate of target-lesion revascularization for the ULMCA lesions (3.6% versus 17.1%, P = 0.005), with similar cardiac death rates at 3 years (9.8% versus 7.6%, P = 0.41). Among patients with bifurcation lesions, patients with stenting of both the main and side branches (n = 119) had significantly higher rates of cardiac death (12.2% versus 5.5%; P = 0.02) and target-lesion revascularization (30.9% versus 11.1%; P < 0.0001) than those with main-branch stenting alone (n = 261). Conclusions-The higher unadjusted mortality rate of patients undergoing ULMCA stenting with a sirolimus-eluting stent did not appear to be related to ULMCA treatment itself but rather to the patients' high-risk profile. Although long-term outcomes in patients with ostial/shaft ULMCA lesions were favorable, outcomes in patients with bifurcation lesions treated with stenting of both the main and side branches appeared unacceptable. (Circulation. 2009;120:1866-1874.)
引用
收藏
页码:1866 / U50
页数:16
相关论文